| CRC | Colorectal Cancer |
| MSI-H | Microsatellite Instability-High |
| dMMR | Deficient Mismatch Repair |
| BCG | Bacillus Calmette–Guérin |
| FDA | Food and Drug Administration |
| TAA | Tumor-Associated Antigen |
| TSA | Tumor-Specific Antigen |
| CTL | Cytotoxic T Lymphocyte |
| DC | Dendritic Cell |
| GMP | Good Manufacturing Practice |
| GVAX | GM-CSF-secreting Allogeneic Tumor Cell Vaccine |
| GM-CSF | Granulocyte–Macrophage Colony-Stimulating Factor |
| DFS | Disease-Free Survival |
| mRNA | Messenger Ribonucleic Acid |
| shRNA | Short Hairpin RNA |
| DNA | Deoxyribonucleic Acid |
| ICI | Immune Checkpoint Inhibitor |
| TME | Tumor Microenvironment |
| MSS | Microsatellite Stable |
| pMMR | Proficient Mismatch Repair |
| MRD | Minimal Residual Disease |
| KRAS | Kirsten Rat Sarcoma Viral Oncogene Homolog |
| CTC | Circulating Tumor Cell |
| PD-L1 | Programmed Death-Ligand 1 |
| iPSC | Induced Pluripotent Stem Cell |
| hESC | Human Embryonic Stem Cells |
| CD4+ | Cluster of Differentiation 4 Positive (T Cell) |
| CD8+ | Cluster of Differentiation 8 Positive (T Cell) |
| HNRNPU | Heterogeneous Nuclear Ribonucleoprotein U |
| NCL | Nucleolin |
| CD40L | CD40 ligand |
| Th1 | Type 1 T Helper Cell |
| HER | Human Epidermal Growth Factor Receptor 2 |
| Treg | Regulatory T Cell |
| MDSC | Myeloid-Derived Suppressor Cell |
| HLA | Human Leukocyte Antigen |
| VEGFR | Vascular Endothelial Growth Factor Receptor |
| CEA | Carcinoembryonic Antigen |